Drug application
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE (MAGNESIUM SULFATE ANHYDROUS, POTASSIUM SULFATE, SODIUM SULFATE)
Drugs@FDA ANDA 203102 · PADDOCK LLC
Key facts
| Drug name | MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE |
|---|---|
| Active ingredients | MAGNESIUM SULFATE ANHYDROUS, POTASSIUM SULFATE, SODIUM SULFATE |
| Application type | ANDA |
| Application number | 203102 |
| Company | PADDOCK LLC |
| Dosage forms | SOLUTION, ORAL |
| Strength | 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Aug 18, 2016 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: